Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A novel tetracycline-inducible viral replication switch.

F Yao1, E Eriksson

  • 1Brigham and Women's Hospital, and Department of Surgery, Harvard Medical School, Boston, MA 02115, USA. FYao@RICS.BWH.Harvard.Edu

Human Gene Therapy
|February 27, 1999
PubMed
Summary

This study developed a novel herpes simplex virus type 1 (HSV-1) replication switch. This switch reversibly controls HSV-1 DNA replication using a tetracycline-regulated system, offering new antiviral strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of intratumoral immunostimulatory LOAd703 gene therapy combined with chemotherapy in patients with advanced cancer.

Immuno-oncology technology·2026
Same author

LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial.

Nature communications·2026
Same author

Correction for Göransson et al., "Performance of a System for Rapid Phenotypic Antimicrobial Susceptibility Testing of Gram-Negative Bacteria Directly From Positive Blood Culture Bottles".

Journal of clinical microbiology·2023
Same author

Preceptors' experiences of supervising internationally educated nurses attending a bridging program: An interview study.

Nurse education today·2023
Same author

Performance of a System for Rapid Phenotypic Antimicrobial Susceptibility Testing of Gram-Negative Bacteria Directly from Positive Blood Culture Bottles.

Journal of clinical microbiology·2023
Same author

Three paths to a Swedish nursing license: Two for internationally educated nurses and one for regular nursing students - A cross-sectional study of self-rated professional competence, self-efficacy, and thriving.

Nurse education today·2022

Area of Science:

  • Molecular Virology
  • Gene Therapy
  • Antiviral Development

Background:

  • Herpes Simplex Virus type 1 (HSV-1) replication relies on its origin-binding protein UL9.
  • Controlling viral replication is crucial for developing effective antiviral therapies.

Purpose of the Study:

  • To engineer a novel, reversible HSV-1-specific viral replication switch.
  • To demonstrate the regulation of HSV-1 DNA plaque-forming efficiency using a tetracycline-controlled system.

Main Methods:

  • Cloning of a trans-dominant negative mutant UL9 (UL9-C535C) under a tetracycline-responsive promoter (pcmvtetO).
  • Utilizing a tetracycline repressor (tetR)-mediated transcription repression switch to control viral replication.
  • Performing transient viral infection assays to measure plaque-forming efficiency.

Related Experiment Videos

Main Results:

  • Reversible regulation of HSV-1 DNA plaque-forming efficiency over 100-fold by tetR.
  • Significantly reduced HSV-1 production (<0 PFU/ml) in the presence of tetracycline compared to absence (~1000 PFU/ml).
  • Tetracycline treatment did not affect HSV-1 synthesis in control cells without the switch.

Conclusions:

  • Established a reversible HSV-1 replication switch by silencing UL9-C535C antiviral activity.
  • This switch enables the development of next-generation HSV-1 recombinants capable of self-inhibition and wild-type virus inhibition.